Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Randomized Trial of Interpectoral Nerve Block (Pecs 1 and 2) With Ropivacaine Versus Placebo Before Breast Cancer Surgery: Effects on Acute Postoperative Pain. (MIRs 04)

NCT04327063 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT04327063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04327063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Randomized Trial of Interpectoral Nerve Block (Pecs 1 and 2) With Ropivacaine Versus Placebo Before Breast Cancer Surgery: Effects on Acute Postoperative Pain. (MIRs 04)
Lead sponsor
Institut Curie
Phase
Phase 3
Overall status
Completed
Start date
August 4, 2020
Completion date
January 28, 2022
Enrollment
182 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm of breast